These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 34453903)

  • 21. Regression of left ventricular hypertrophy after surgical therapy for aortic stenosis is associated with changes in extracellular matrix gene expression.
    Walther T; Schubert A; Falk V; Binner C; Kanev A; Bleiziffer S; Walther C; Doll N; Autschbach R; Mohr FW
    Circulation; 2001 Sep; 104(12 Suppl 1):I54-8. PubMed ID: 11568030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis.
    Weinberg EO; Schoen FJ; George D; Kagaya Y; Douglas PS; Litwin SE; Schunkert H; Benedict CR; Lorell BH
    Circulation; 1994 Sep; 90(3):1410-22. PubMed ID: 8087951
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac matrix metalloproteinase-2 expression independently induces marked ventricular remodeling and systolic dysfunction.
    Bergman MR; Teerlink JR; Mahimkar R; Li L; Zhu BQ; Nguyen A; Dahi S; Karliner JS; Lovett DH
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1847-60. PubMed ID: 17158653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TNF-α inhibition decreases MMP-2 activity, reactive oxygen species formation and improves hypertensive vascular hypertrophy independent of its effects on blood pressure.
    Mattos BR; Bonacio GF; Vitorino TR; Garcia VT; Amaral JH; Dellalibera-Joviliano R; Franca SC; Tanus-Santos JE; Rizzi E
    Biochem Pharmacol; 2020 Oct; 180():114121. PubMed ID: 32592722
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tempol inhibits TGF-β and MMPs upregulation and prevents cardiac hypertensive changes.
    Rizzi E; Castro MM; Ceron CS; Neto-Neves EM; Prado CM; Rossi MA; Tanus-Santos JE; Gerlach RF
    Int J Cardiol; 2013 Apr; 165(1):165-73. PubMed ID: 21917342
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term MMP inhibition by doxycycline exerts divergent effect on ventricular extracellular matrix deposition and systolic performance in stroke-prone spontaneously hypertensive rats.
    Zeng S; Zhou X; Tu Y; Yao M; Han ZQ; Gao F; Li YM
    Clin Exp Hypertens; 2011; 33(5):316-24. PubMed ID: 21649529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Temporal changes in cardiac matrix metalloproteinase activity, oxidative stress, and TGF-β in renovascular hypertension-induced cardiac hypertrophy.
    Rizzi E; Ceron CS; Guimaraes DA; Prado CM; Rossi MA; Gerlach RF; Tanus-Santos JE
    Exp Mol Pathol; 2013 Feb; 94(1):1-9. PubMed ID: 23073243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Euterpe oleracea Mart.-derived polyphenols prevent endothelial dysfunction and vascular structural changes in renovascular hypertensive rats: role of oxidative stress.
    da Costa CA; de Oliveira PR; de Bem GF; de Cavalho LC; Ognibene DT; da Silva AF; Dos Santos Valença S; Pires KM; da Cunha Sousa PJ; de Moura RS; Resende AC
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Dec; 385(12):1199-209. PubMed ID: 23052352
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of matrix metalloproteinases prevents peroxynitrite-induced contractile dysfunction in the isolated cardiac myocyte.
    León H; Baczkó I; Sawicki G; Light PE; Schulz R
    Br J Pharmacol; 2008 Feb; 153(4):676-83. PubMed ID: 18071296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism.
    Neto-Neves EM; Sousa-Santos O; Ferraz KC; Rizzi E; Ceron CS; Romano MM; Gali LG; Maciel BC; Schulz R; Gerlach RF; Tanus-Santos JE
    J Cell Mol Med; 2013 Dec; 17(12):1588-97. PubMed ID: 24199964
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of dystrophin is associated with increased myocardial stiffness in a model of left ventricular hypertrophy.
    Donato M; Buchholz B; Morales C; Valdez L; Zaobornyj T; Baratta S; Paez DT; Matoso M; Vaccarino G; Chejtman D; Agüero O; Telayna J; Navia J; Hita A; Boveris A; Gelpi RJ
    Mol Cell Biochem; 2017 Aug; 432(1-2):169-178. PubMed ID: 28316061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased rho-kinase activity in hypertensive patients with left ventricular hypertrophy.
    Gabrielli L; Winter JL; Godoy I; McNab P; Padilla I; Cordova S; Rigotti P; Novoa U; Mora I; García L; Ocaranza MP; Jalil JE
    Am J Hypertens; 2014 Jun; 27(6):838-45. PubMed ID: 24363278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quercetin decreases cardiac hypertrophic mediators and maladaptive coronary arterial remodeling in renovascular hypertensive rats without improving cardiac function.
    da Rocha EV; Falchetti F; Pernomian L; de Mello MMB; Parente JM; Nogueira RC; Gomes BQ; Bertozi G; Sanches-Lopes JM; Tanus-Santos JE; Castro MM
    Naunyn Schmiedebergs Arch Pharmacol; 2023 May; 396(5):939-949. PubMed ID: 36527481
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of matrix metalloproteinase-2 improves endothelial function and prevents hypertension in insulin-resistant rats.
    Nagareddy PR; Rajput PS; Vasudevan H; McClure B; Kumar U; Macleod KM; McNeill JH
    Br J Pharmacol; 2012 Feb; 165(3):705-15. PubMed ID: 21740410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Congenic expression of tissue inhibitor of metalloproteinase in Dahl-salt sensitive hypertensive rats is associated with reduced LV hypertrophy.
    Rodriguez WE; Tyagi N; Deng AY; Adeagbo A; Joshua IG; Tyagi SC
    Arch Physiol Biochem; 2008 Dec; 114(5):340-8. PubMed ID: 19003589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amlodipine and Atorvastatin Improved Hypertensive Cardiac Remodeling through Regulation of MMPs/TIMPs in SHR Rats.
    Lu J; Hao J; Du H; Xiao B; Li Y; Yang X; Cui W
    Cell Physiol Biochem; 2016; 39(1):47-60. PubMed ID: 27322513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Troponin I serum concentration: a new marker of left ventricular hypertrophy in patients with essential hypertension.
    Siciliano M; Mettimano M; Dondolini-Poli A; Ballarin S; Migneco A; Annese R; Fazzari L; Fedeli P; Montebelli MR; Zuppi C; Savi L
    Ital Heart J; 2000 Aug; 1(8):532-5. PubMed ID: 10994933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Doxycycline attenuates isoproterenol-induced myocardial fibrosis and matrix metalloproteinase activity in rats.
    Hori Y; Kunihiro S; Sato S; Yoshioka K; Hara Y; Kanai K; Hoshi F; Itoh N; Higuchi S
    Biol Pharm Bull; 2009 Oct; 32(10):1678-82. PubMed ID: 19801827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antioxidant effect of doxycycline decreases MMP activity and blood pressure in SHR.
    Antonio RC; Ceron CS; Rizzi E; Coelho EB; Tanus-Santos JE; Gerlach RF
    Mol Cell Biochem; 2014 Jan; 386(1-2):99-105. PubMed ID: 24114660
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension, augmented activity of matrix metalloproteinases-2 and -9 and angiogenic imbalance in hypertensive pregnancy are attenuated by doxycycline.
    Nascimento RA; Possomato-Vieira JS; Gonçalves-Rizzi VH; Bonacio GF; Rizzi E; Dias-Junior CA
    Eur J Pharmacol; 2018 Dec; 840():60-69. PubMed ID: 30336141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.